News Conference News AHA 2022 Pemafibrate Fails to Lower CVD Risk in Patients With High Triglycerides: PROMINENT Michael O'Riordan November 05, 2022
News Daily News CV Risk Factors, Disease Projected to Explode in Coming Decades L.A. McKeown August 01, 2022
News Conference News EAS 2022 Lp(a) Linked to ASCVD and Aortic Stenosis Regardless of CRP Level Michael O'Riordan May 24, 2022
News Conference News EAS 2022 ROSE Trial: CETP Inhibitor Shows Promise as Oral Add-on for LDL-Lowering Michael O'Riordan May 24, 2022
News Features Aortic Valve Replacement: What’s on the Wish List for Future Devices? Shelley Wood March 14, 2022
News Daily News Statin Intolerance Overestimated—Only ‘Small Number’ Get Side Effects: Meta-analysis Michael O'Riordan February 18, 2022